Welcome to our dedicated page for Cellebrite Di news (Ticker: CLBT), a resource for investors and traders seeking the latest updates and insights on Cellebrite Di stock.
Cellebrite DI Ltd. reports developments in AI-powered digital investigative and intelligence software for public and private sector customers. Its updates cover digital forensics, lawful device access, evidence analysis, investigative collaboration, application security and cloud deployment, including Cellebrite Government Cloud, Guardian Investigate, Genesis and Corellium.
Company news also includes federal cloud-security authorization, product releases, financial results, annual reporting, investor conference participation and product and technology leadership changes. Cellebrite’s software portfolio supports law enforcement agencies, defense and intelligence organizations, enterprises and service providers across cloud, on-premises and hybrid deployments.
Cellebrite (NASDAQ: CLBT) completed its acquisition of SCG Canada, Inc. on March 2, 2026, adding hand-held UAV/drone forensic capabilities that access data from more than 80 common UAVs.
The integration extends Cellebrite's AI-powered platform to drone flight logs, video and other mission-critical artifacts; financial terms were not disclosed.
Cellebrite (NASDAQ: CLBT) will participate in the Morgan Stanley Technology, Media & Telecom Conference on March 3, 2026. The company will appear in a 10:45 a.m. ET fireside chat featuring CFO David Barter and VP of Investor Relations Andrew Kramer. Details and a webcast link are available.
Cellebrite (NASDAQ: CLBT) reported record fourth-quarter and full-year 2025 results with Q4 revenue $128.8M (+18% YoY), total ARR $480.8M (+21% YoY) and FY revenue $475.7M (+19% YoY). Non-GAAP net income was $130.5M for FY2025 and adjusted EBITDA was $38.3M in Q4 (29.8% margin) and $127.6M for the year (26.8% margin). The company completed the acquisition of Corellium on Dec 1, 2025 (adding $16.1M ARR) and announced an agreement to acquire SCG Canada for drone forensics. 2026 guidance targets ARR of $567M–$573M and revenue of $565M–$571M.
Cellebrite (NASDAQ: CLBT) released its 2026 Industry Trends Report surveying 1,200 practitioners across 63 countries. Key findings: 97% cite smartphones as the top source of digital evidence (up 24 points from 2024), 95% say digital evidence raises solvability, and 65% expect AI to accelerate investigations.
Cloud receptiveness rose to 42%, though two-thirds still share evidence via physical media, creating custody risks. Guardian platform saw triple-digit YoY growth in customers, users and data stored in 2025.
Cellebrite (NASDAQ: CLBT) announced it will report fourth-quarter and fiscal year 2025 financial results before U.S. markets open on Wednesday, February 11, 2026. A live conference call and webcast to review Q4 2025 results and discuss the company’s 2026 outlook will follow at 8:30 a.m. ET the same day.
Call-in numbers, conference ID CLBTQ425, and live webcast links are provided; historical financial tables and supplemental data will be posted to the company’s quarterly results page on the investor relations website.
Cellebrite (NASDAQ: CLBT) completed the acquisition of Corellium on Dec 2, 2025, combining Corellium’s Arm-based virtualization with Cellebrite’s AI-powered digital investigation platform.
The transaction value was $170 million (including $150 million cash at closing, $20 million converted to equity, and up to $30 million in performance-based cash over two years). Corellium CTO Chris Wade joined Cellebrite as CTO. CFIUS permitted closing under a negotiated national security agreement pending formal agency execution. Cellebrite said one month of Corellium results will not materially affect 2025 outlook.
Cellebrite (NASDAQ: CLBT) reported third-quarter 2025 results with ARR $439.8M (+19%) and revenue $126.0M (+18%). Subscription revenue reached $112.7M (+21%) and recurring revenue NRR was 117%. GAAP net income was $20.2M; non-GAAP net income was $36.9M. Adjusted EBITDA was $37.7M with a 29.9% margin. Management reiterated full-year 2025 targets (ARR $460M–$475M; revenue $470M–$475M) and Q4 revenue guidance of $123M–$128M. Guidance excludes any contribution from the pending Corellium acquisition. The company highlighted product releases (Autumn 2025), Guardian Investigate SaaS (GA), and leadership hire for general counsel and compliance.
Cellebrite (Nasdaq: CLBT) announced on Oct 30, 2025 the appointment of Holly Windham as General Counsel and Chief Compliance Officer. She will oversee all legal and compliance matters and support efforts to ensure appropriate global use of Cellebrite technology. Ms. Windham succeeds Ayala Berler Shapira.
Ms. Windham previously served as Chief Legal Officer and Board Secretary at Self Financial, which serves more than 1.7 million consumers, and held multiple senior roles at Rackspace Technology, a $3 billion+ multi-cloud company where she led a team of 180 and participated in IPO and M&A activity exceeding $1 billion. She holds a J.D. from Pepperdine and a B.A. from Southwestern Oklahoma State University.
Cellebrite (NASDAQ: CLBT) announced that actor and advocate Terry Crews will headline its C2C User Summit 2026, taking place April 13–17, 2026 at the Washington, D.C. Marriott Marquis.
The second annual summit gathers public safety and private sector digital investigation professionals for immersive training, thought leadership, networking and qualified professional credit. Crews will share personal lessons on resilience and advocacy against human trafficking and abuse. The event features the Digital Justice Awards (Justys) and will showcase Cellebrite innovations including the newly added Corellium technology.
Cellebrite (NASDAQ: CLBT) will report its third-quarter 2025 financial results after the U.S. market close on Wednesday, November 12, 2025.
The company will host a live conference call and webcast at 5:00 p.m. ET the same day to review Q3 2025 results and discuss its full-year 2025 outlook. Participants can join via the provided call-in numbers or the live webcast, and historical financial tables and supplemental data will be posted on the quarterly results section of the company investor relations website.